Skip to content
Achondroplasia Research Conference
Home
Speakers
Venue
Schedule
Sponsors
Sponsorship & Supporter Opportunities
News
The Chandler Project Presents the 3rd Annual
Achondroplasia Research Conference
Royal Sonesta Harbor Court Baltimore - 550 Light St. Baltimore, MD 21202
Register
Book Hotel
1:00 pm -
2:00 pm
July 2, 2021 -
July 3, 2021
Category:
Ascendis
Achondroplasia
Ascendis
BioMarin
Pfizer
QED
Prospects for Pharmaceutical Treatment of Achondroplasia
January 18, 2021
achondroplasia
clinical trial
epiphyseal plate
Fibroblast growth factor receptor 3
protein cartilage
Receptor (biochemistry)
vosoritide
John B. Cannon, Ph.D Achondroplasia is a form of dwarfism that occurs about once in every 20,000 births. It...
Read More
Ascendis
Ascendis Pharma Announces Orphan Drug Designation Granted for TransCon CNP as Treatment for Achondroplasia
February 28, 2019
achondroplasia
C-type Natriuretic Peptide
orphan drug
peptide
TransCon
TransCon CNP
treatment
COPENHAGEN, Denmark, Feb. 28, 2019 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technology to address...
Read More
Write a Comment...
Email (Required)
Name (Required)
Website
Loading Comments...
Comment
×
